PRAS40 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of PRAS40 monoclonal antibodies for research focused on understanding PRAS40's role in cellular signaling pathways. PRAS40 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRAS40, a key regulator of the mTOR signaling pathway, plays a critical role in cell growth, metabolism, and survival. Through interactions with various cellular components, PRAS40 modulates the activity of mTORC1, influencing processes such as protein synthesis and autophagy. Understanding PRAS40 function is essential for elucidating its implications in cancer and metabolic disorders. PRAS40 research continues to reveal new insights into cellular regulation mechanisms and potential therapeutic targets. Ongoing studies of PRAS40 signaling networks contribute to our understanding of disease progression and treatment strategies. Research utilizing PRAS40 monoclonal antibodies has expanded knowledge of cellular growth control and metabolic regulation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PRAS40's role in health and disease.